Agile Therapeutics (AGRX) Insider Trading & Ownership

$0.40
0.00 (0.00%)
(As of 04/25/2024 ET)

Agile Therapeutics (NASDAQ:AGRX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
0.50%
Number Of
Insiders Buying
(Last 3 Years)
3
Amount Of
Insider Buying
(Last 3 Years)
$5.04 M
Number Of
Insiders Selling
(Last 3 Years)
0
Get AGRX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Agile Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

AGRX Insider Buying and Selling by Quarter

Agile Therapeutics Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
8/26/2022Alfred AltomariCEOBuy50,000$0.45$22,500.00  
10/13/2021Perceptive Advisors LlcMajor ShareholderBuy5,734,560$0.85$4,874,376.00  
7/29/2021Alfred AltomariCEOBuy26,200$1.26$33,012.00  
7/27/2021Dennis ReillyCFOBuy50,000$1.08$54,000.00  
5/18/2021Alfred AltomariCEOBuy20,000$1.61$32,200.00  
5/11/2021Dennis ReillyCFOBuy20,000$1.35$27,000.00  
(Data available from 1/1/2013 forward)

AGRX Insider Trading Activity - Frequently Asked Questions

Who is on Agile Therapeutics's Insider Roster?

The list of insiders at Agile Therapeutics includes Alfred Altomari, Dennis Reilly, and Perceptive Advisors Llc. Learn more on insiders at AGRX.

What percentage of Agile Therapeutics stock is owned by insiders?

0.50% of Agile Therapeutics stock is owned by insiders. Learn more on AGRX's insider holdings.

Which Agile Therapeutics insiders have been buying company stock?

The following insider purchased AGRX shares in the last 24 months: Alfred Altomari ($22,500.00).

How much insider buying is happening at Agile Therapeutics?

Insiders have purchased a total of 50,000 AGRX shares in the last 24 months for a total of $22,500.00 bought.


More Insider Trading Tools from MarketBeat

This page (NASDAQ:AGRX) was last updated on 4/25/2024 by MarketBeat.com Staff

From Our Partners